Literature DB >> 12033769

Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2.

Luise Florin1, Frank Schäfer, Karl Sotlar, Rolf E Streeck, Martin Sapp.   

Abstract

Nuclear domains (ND) 10 are associated with proteins implicated in transcriptional regulation, growth suppression, and apoptosis. We now show that the minor capsid protein L2 of human papillomavirus (HPV) type 33 induces a reorganization of ND10-associated proteins. Whereas the promyelocytic leukemia protein, the major structural component of ND10, was unaffected by L2, Sp100 was released from ND10 upon L2 expression. The total cellular amount of Sp100, but not of Sp100 mRNA, decreased significantly, suggesting degradation of Sp100. Proteasome inhibitors induced the dispersal of Sp100 and inhibited the nuclear translocation of L2. In contrast to Sp100, Daxx was recruited to ND10 by L2 expression. Coimmunoprecipitation demonstrated interaction of the two proteins. L2-induced reorganization of ND10 was observed both in cell culture and in natural HPV lesions. The differential change in protein composition observed provides further evidence to suggest that the ND10-associated proteins are an important interface of viral life cycle and host cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033769     DOI: 10.1006/viro.2002.1360

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  Assembly and translocation of papillomavirus capsid proteins.

Authors:  Luise Florin; Cornelia Sapp; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 4.  Hitchhiking on host chromatin: how papillomaviruses persist.

Authors:  Alison A McBride; Nozomi Sakakibara; Wesley H Stepp; Moon Kyoo Jang
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 5.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

6.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Daxx silencing sensitizes cells to multiple apoptotic pathways.

Authors:  Liuh-Yow Chen; J Don Chen
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions.

Authors:  Yukiko Shishido-Hara; Shizuko Ichinose; Kayoko Higuchi; Yoshinobu Hara; Kotaro Yasui
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

10.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.